Discontinued — last reported Q2 '23
Roper Technologies, Inc. Acquisitions increased by 186.5% to $27.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 78.0%, from $124.90M to $27.50M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 97.3% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.50M | $3.90M | $197.60M | $53.20M | $205.70M | $322.00M | $3.70B | $1.10M | $16.20M | $1.95B | $82.60M | $1.86B | -$400.00K | $1.61B | $148.80M | $124.90M | $1.88B | $1.28B | $9.60M | $27.50M |
| QoQ Change | — | -74.8% | >999% | -73.1% | +286.7% | +56.5% | >999% | -100.0% | >999% | >999% | -95.8% | >999% | -100.0% | >999% | -90.7% | -16.1% | >999% | -32.2% | -99.2% | +186.5% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -97.9% | -92.1% | +506.5% | -97.8% | >999% | -102.5% | -17.8% | +80.1% | -93.3% | >999% | -20.6% | -93.5% | -78.0% |